DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Herrlinger K, Witthoft T, Raedler A. et al.
Randomized, double blind controlled trial of subcutaneous recombinant human interleukin-11 vs. prednisolone in active Crohn’s disease.
Am J Gastroenterol 2005; (im Druck): -
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.